Coronavirus disease 2019

doi:10.3969/j.issn.1006-7795.2020.02.001

Abstract

CLC Number:

R563.1

Jin Ronghua. Coronavirus disease 2019[J]. Journal of Capital Medical University, 2020, 41(2): 149-154.

[1] Gorbalenya A E, Baker S C, Baric R S, et al. Severe acute respiratory syndrome-related coronavirus:the species and its viruses-a statement of the Coronavirus Study Group. Preprint. bioRxiv. (2020-02-11)[2020-02-23]. https://doi.org/10.1101/2020.02.07.937862.
[2] Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses[J]. Trends Microbiol,2016,24:490-502.
[3] Chan J F, Lau S K, To K K, et al. Middle East respiratory syndrome coronavirus:another zoonotic beta coronavirus causing SARS-like disease[J]. Clin Microbiol Rev,2015,28:465.
[4] Zhong N S, Zheng B J, Li Y M, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003[J]. Lancet,2003,362:1353-1358.
[5] Ksiazek T G, Erdman D, Goldsmith C S, et al. A novel coronavirus associated with severe acute respiratory syndrome[J]. N Engl J Med,2003,348:1953-1966.
[6] Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med,2003,348:1967-1976.
[7] Zaki A M, van Boheemen S, Bestebroer T M, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med,2012,367:1814-1820.
[8] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med,2020,382:727-733.
[9] Gaunt E R, Hardie A, Claas E C, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method[J]. J Clin Microbiol,2010,48:2940-2947.
[10] Duarte R, Furtado I, Sousa L,et al. The 2019 novel coronavirus (2019-nCoV):novel virus, old challenges. Acta Med Port,2020, 33:155-157. https://doi.org/10.20344/amp.13547.
[11] Zhou P, Yang X L, Wang X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020-02-03)[2020-02-23].https://doi.org/10.1038/s41586-020-2012-7.
[12] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding. Lancet.(2020-01-30)[2020-02-23]. https://doi.org/10.1016/S0140-6736(20)30251-8.
[13] Xiao K, Zhai J, Feng Y, et al. Isolation and characterization of 2019-nCoV-like coronavirus from Malayan Pangolins. Preprint. bioRxiv. (2020-02-20)[2020-02-23]. https://doi.org/10.1101/2020.02.17.951335.
[14] 中华预防医学会新型冠状病毒肺炎防控专家组. 新型冠状病毒肺炎流行病学特征的最新认识[J].中华流行病学杂志,2020,41(2):139-144.
[15] WHO. Statement on the meeting of the International Health Regulations(2005) Emergency Committee regarding the outbreak of novel coronavirus 2019-nCoV).(2020-01-21)[2020-02-22].https://www.who.int/westernpacific/emergencies/covid-19.
[16] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志,2020,41(2):145-151.
[17] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. (2020-01-29)[2020-02-23].https://doi.org/10.1056/NEJMoa2001316.
[18] WHO. Novel coronavirus (2019-nCoV) technical guidance. N Engl J Med. (2020-01-29)[2020-02-23].https://doi.org/10.1056/NEJMoa2001316.
[19] Liu Y C, Liao C H, Chang C F, et al. A locally transmitted case of SARS-CoV-2 infection in Taiwan. N Engl J Med.(2020-02-12)[2020-02-23].https://doi.org/10.1056/NEJMc2001573.
[20] Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany. N Engl J Med.(2020-01-30)[2020-02-22].https://doi.org/10.1056/NEJMc2001468.
[21] Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science. (2020-02-03)[2020-02-22].https://www.sciencemag.org/news/2020/02/paper-non-symptomatic-patient-transmitting-coronavirus-wrong.
[22] Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection. (2020-02-12)[2020-02-23]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
[23] Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan:an analysis based on decade-long structural studies of SARS. J Virol. (2020-01-29)[2020-02-23].https://doi.org/10.1128/JVI.00127-20.
[24] Imai Y, Kuba K, Rao S, et al. Angiotensin converting enzyme 2 protects from severe acute lung failure[J]. Nature,2005,436:112-116.
[25] Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2(ACE2) in SARS coronavirus induced lung injury[J]. Nat Med,2005,11:875-879.
[26] Menachery V D, Eisfeld A J, Schafer A, et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon stimulated gene responses[J]. Micro Bio,2014,5:e01174-14.
[27] Lau S K, Lau C C, Chan K H,et al.Delayed induction of proin flammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus:implications for pathogenesis and treatment[J]. J Gen Virol, 2013,94:2679-2690.
[28] Channappanavar R, Perlman S. Pathogenic human coronavirus infections:causes and consequences of cytokine storm and immunopathology[J]. Semin Immunopathol,2017,39:529.
[29] 沈华浩, 丁礼仁. 严重急性呼吸综合征发病机制研究现状[J]. 中华急诊医学杂志, 2003,12(8):568-569.
[30] Liu J, Zheng X, Tong Q, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. (2020-02-13)[2020-02-23]. https://doi.org/10.1002/jmv.25709.
[31] Guan W J, Ni Z Y, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China Preprint.bioRxiv. (2020-02-09)[2020-02-23].https://doi.org/10.1101/2020.02.06.20020974.
[32] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020,395:497-506.
[33] 国家卫生健康委办公厅.新型冠状病毒感染的肺炎诊疗方案(试行第六版). (2020-02-21)[2020-02-22].http://www.nhe.gov.cn/yzygi/s7652m/202002/54elad5c2aac45c19eb541799b1637e9.shtml.

Coronavirus disease 2019

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Xue, Jia Hongxiao, Zhu Hong, Feng Zhengtian, Zheng Sisi, Wu Ziyao, Duan Yuhang. Research on core syndrome of generalized anxiety disorder in traditional Chinese medicine: based on network analysis method [J]. Journal of Capital Medical University, 2025, 46(3): 471-478.
[2]	Jiang Huan , Li Jiaoqing, Xu Haosen , Lan Jinyi , Yang Shanzhi , Zhang Ting , Liu Peimin , Wu Danfeng , Bai Xiaoyan. Research progression of slit guidance ligand 3 [J]. Journal of Capital Medical University, 2024, 45(5): 917-922.
[3]	Bai Yu, Tian Dongli. Advance on role of adenosine type 1 receptor in renal diseases [J]. Journal of Capital Medical University, 2024, 45(3): 543-547.
[4]	Li Zhongshu. Understanding eosinophilic gastritis: new research insights [J]. Journal of Capital Medical University, 2024, 45(3): 548-555.
[5]	Wang Husheng, Ruan Xiangyan, Cheng Jiaojiao, Alfred O. Mueck. Study on the relationship between oxidative stress and lipid metabolism in obese women with polycystic ovary syndrome [J]. Journal of Capital Medical University, 2021, 42(4): 540-546.
[6]	Li Xue, Ning Yanzhe, Jia Hongxiao. Identification and intervention strategies for anxiety with traditional Chinese medicine during COVID-19 pneumonia pandemics [J]. Journal of Capital Medical University, 2021, 42(3): 399-403.
[7]	Liu Shanshan, Chen Xu, Li Yaqiong, Yuan Xiaofei, Yu Hongye, Fang Meng. Investigation of depression and anxiety and their influencing factors among adolescents in Beijing during the coronavirus disease 2019 epidemic [J]. Journal of Capital Medical University, 2021, 42(3): 412-417.
[8]	Chen Jianming, Chen Tengfei, Lian Bo, Chen Yishan, Xu Xiaolong, Liu Qingquan. Analysis of the distribution characteristics of Chinese medicine syndromes and syndrome elements in COVID-19 [J]. Journal of Capital Medical University, 2020, 41(6): 901-907.
[9]	Mu Meng, Zhang Junmin, Chen Ruifang, Sun Chaoyuan. Strategy analysis of response of medical science and technology periodicals journals to public health emergencies——a case study of Journal of Capital Medical University [J]. Journal of Capital Medical University, 2020, 41(6): 1033-1036.
[10]	Li Wei, Hao Chanjuan. Exploring the etiology of pediatric inherited disorders——Dr. Li Wei's Laboratory [J]. Journal of Capital Medical University, 2020, 41(5): 730-735.
[11]	Shan Shan, Cong Min. Devoted to the prevention and control of liver diseases——Professor Jia Jidong [J]. Journal of Capital Medical University, 2020, 41(5): 839-843.
[12]	An Yanhong, Rong Dongdong, Shan Yi, Wu Chunxue, Gao Yan, Lu Jie. Comparison of chest radiograph images between suspected and confirmed cases of COVID-19 [J]. Journal of Capital Medical University, 2020, 41(4): 608-612.
[13]	Hu Qi, Zhong Zheng, Liu Jiyang, Tang Yuling, Zhou Zhiguo, Liu Ping, Yan Yusheng, Li Bo. Chest computed tomography characteristics report of 57 patients with COVID-19 [J]. Journal of Capital Medical University, 2020, 41(4): 627-630.
[14]	Yang Yi, Lu Xuran, Liu Nan, Hou Xiaotong, Sun Lizhong, Wu Long, Pan Youmin, Wang Shoufeng, Zhao Xinyan. Effects of COVID-19 on cardiovascular system [J]. Journal of Capital Medical University, 2020, 41(4): 657-663.
[15]	Liu Jingyuan, Guo Hebing, Li Ang. Progress in diagnosis and treatment of critical COVID-19 [J]. Journal of Capital Medical University, 2020, 41(3): 321-327.